Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Institutional Shareholder Services, a major shareholder advisory firm, is urging Mylan stockholders to vote for the removal of 10 board members, including board Chairman Robert Coury and CEO Heather Bresch, reports STAT.
Halyard Health, a medical products supplier, seeks to divest its surgical and infection prevention business, unnamed sources told Reuters.
Drug prices vary greatly among high-income countries with universal healthcare coverage, according to a study published in Canadian Medical Association Journal.
The U.S. Supreme Court on Monday ruled drugmakers will no longer have to wait six months after regulatory approval to launch new biosimilar drugs, reports Reuters.
Lower doses and shorter treatment periods may not reduce the efficacy of many cancer drugs, says a group of oncologists researching ways to lower cancer treatment costs.
Office supplies are typically a large expense for hospitals. Developing and implementing an aggressive, limited office supply formulary can help control these costs, according to Tom Fox, a managing director at healthcare consulting firm Nova Strategies.
The Food and Drug Administration denied Coherus BioSciences' biosimilar version of Amgen's successful cancer drug Neulasta.
Northfield, Ill.-based Medline received Vizient's Mark McKenna Overall Supplier of the Year Award during the 2017 Vizient Supplier Summit held April 3-5 in Las Vegas.
Teva Pharmaceuticals on Friday received Food and Drug Administration approval for the first generic version of Gilead Science's best-selling HIV drug Truvada, reports Regulatory Focus.
Lupin Pharmaceuticals recalled its Mibelas 24 Fe birth control tablets following confirmed reports of a packaging error.